Medicine details

Image Aciphin
Name Aciphin IV 1 gm
Dosage IV Injection
Generic Name Ceftriaxone
Classes Antiinfective Agent
Antibiotic
Cephalosporine
Diseases Bone Infection
Bronchitis
Gonorrhea
Infectious Disease
Meningitis
Otitis
Pelvic Inflammatory Disease (PID)
Pneumonia
Sinusitis
Tonsillitis
Urethritis
Company ACI Limited

Drug Package Details

Strength 1 gm
Storage Condition
Origin Country Bangladesh
Commercial Pack 1
Price per pack 191.29
Cost per pack 168.34
Package unit 1 gm combipack
Price per unit 191.29
Cost per unit 168.34
Discount 0
Coupon
Remarks

Ceftriaxone

Ceftriaxone is a broad-spectrum parenteral cephalosporin antibiotic of the third generation. It has strong bactericidal properties against both Gram-positive and Gram-negative bacteria.

Ceftriaxone is indicated for the following infections causes by susceptible strains-

  • Lower respiratory tract infections
  • Acute Bacterial Otitis Media
  • Skin and skin structure infections
  • Urinary tract infections
  • Gonorrhea
  • Bacterial Septicemia
  • Bone and joint infections
  • Meningitis
  • Prevention of postoperative infections
  • Perioperative prophylaxis of infections associated with surgery
  • Lyme disease

Ceftriaxone is only available as intravenous and intramuscular injection. The usual dose for adults is 1-2 gm per day.

The common side effects of ceftriaxone are-

  • Nausea
  • Vomiting
  • Diarrhea
  • Eosinophilia
  • Thrombocytosis

 

  • Hypersensitivity reaction & Anaphylactic shock may occur, in such cases immediate clinical attention is required.
  • Severe cases of hemolytic anemia, including fatalities in adults and children, have been reported.
  • Interaction with Calcium-containing Products: Precipitation can occur. Do not administer simultaneously with calcium-containing IV solutions.
  • Patients with both hepatic and renal impairment should not received more than 2 grams of ceftriaxone per day.

Contraindication

Contraindicated in patients hypersensitive to any beta lactam antibiotics such as-

Ceftriaxone is contraindicated in newborns under 28 days.